# Phase 3 Study to Compare the Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media

> **NCT02044341** · PHASE3 · COMPLETED · sponsor: **Arbor Pharmaceuticals, Inc.** · enrollment: 304 (actual)

## Conditions studied

- Acute Otitis Media

## Interventions

- **DRUG:** AR01
- **DRUG:** Glycerin ear drops

## Key facts

- **NCT ID:** NCT02044341
- **Lead sponsor:** Arbor Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 304 (ACTUAL)
- **Last updated:** 2015-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02044341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02044341, "Phase 3 Study to Compare the Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02044341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*